Professional
Added to YB: 2026-06-22
Pitch date: 2026-05-20
DHR [bullish]
Danaher Corporation
+4.5%
current return
Author Info
No bio for this author
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$125.4B
Pitch Price
$173.54
Price Target
N/A
Dividend
0.90%
EV/EBITDA
16.88
P/E
34.34
EV/Sales
5.63
Sector
Life Sciences Tools and Services
Category
growth
Eagle Capital Management New Position: Danaher Corporation
DHR (new position): Leading life sciences co w/ mission-critical consumables/tooling for R&D, diagnostics, biopharma. High share, strong mgmt. Depressed multiple on depressed earnings post-Covid/biotech crash/China/NIH cuts. Expect improving growth, mid-teens EPS, AI biopharma upside.
Read full article (1 min)